Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Equillium Inc (EQ)

NASDAQ
Currency in USD
Disclaimer
1.710
-0.100(-5.52%)
Closed
After Hours
1.790+0.080(+4.678%)

EQ Comments

Tiempo de comprar, creo.. como lo ven?
should I buy EQ at 3.80?
bought again
spike to come!!
Nice Filippo I bought at spike
 mee too.... people sell the news here like in the 90ies
fantastic! almost no resistance up to 12.5 then easily at 18 in the sky!!!!
Equillium, Inc.  today announced that it has entered into a securities purchase agreement with life science institutional investment funds managed by Decheng Capital, to purchase 4,285,710 units (the “Units”) from Equillium, with each Unit consisting of one share of common stock and a warrant to purchase 0.3 of a share of common stock. The purchase price per Unit is $7.00, priced above the market under Nasdaq rules. The warrants will have an exercise price of $14.00 per share, will be immediately exercisable, and will expire on the earlier of (i) the fifth anniversary of issuance, or (ii) the 15th calendar date following the date on which Equillium closes a financing raising a minimum of $25 million at a price per share of no less than $25.00.
super bullish
flying high in pre-market! chickens left last week! time to race high!!!
this seems fantastic! biospace.com/article/novel-therapeutic-offers-immune-regulation-for-immuno-inflammatory-diseases
sounds really transformative! curious to listen to the oral presentation!
Do you expect to go up more than this?
lets goooo!!!! 🚀🚀🚀🚀🚀
Any info?
 news?
How are we going??
To late??
dude this is gonna be 2x in the 1q
EQ is soaring it will rise 8.23 by next week
Why? Please explain
Phase 3 results are very close, buy now or die
Guys, do you think this is a long term? Got in at 5.06.
5.30 in pre market
Guys, do you think this is a long term? Got in at 5.06.
I bought at 6.3 🥺🥺 should i wait or sell?
Sell
I bought at 6.3 🥺🥺 should i wait or sell?
🤣🤣🤣
me too trapped at 6.20😁
don't ever sell...there is earnings on FEB
It was great!!  $$$$  EQ is the best, I'll be IN again very soon. Thanks all.  Well... next trip... INDIA GLOBALIZATION CAPITAL INC  >cannabis is here, also a know how renew-company and my bet for Biden's new US  >Good luck everyone here!  lol
where did you get the signal to get in?
The signal was EQ news they are top,I buy at $5, 4, and the very dip, also today to market when flying, to win more  ;p
 Yes, news. Buy at $6, 4.5 and 3.5 and again today as soon as this rally started  $$$$
Equillium Announces Positive Interim Data of Itolizumab to treat severe autoimmune and inflammatory disorders.
https://ir.equilliumbio.com/news-releases/news-release-details/equillium-receives-fda-clearance-covid-19-ind-phase-3-trial
What’s going on with one ? I thought this would go up after closing on shares sell at $7.
Not sure when but this is gonna fly. See today's news out of India below:https://m.mid-day.com/amp/articles/covid19-amid-shortage-of-tocilizumab-drug-in-mumbai-experts-question/22943211?__twitter_impression=true
Where is this heading next week ?
11:32 AT&T DH DECCAN HERALD SUPPORT DH JOURNALISM Dr S Sacchidanand, Vice-Chancellor, Rajiv Gandhi University of Health Sciences, who heads the state therapeutic committee that approves the treatment protocol for Covid-19 from time to time is however optimistic about the investigational therapies despite latest revelations about the efficacy of these drugs. About Itolizumab (a drug that is branded as "restricted emergency use'), he said, "We are discussing it in our next meet of the state therapeutic committee. The rejection has only come recently. It has to be officially communicated. Till then we will have to withdraw." Seema Ahuja, Global Head of Communications at Biocon was not available for comment on the same to DH. Also Read: Russia approves coronavirus 3 Valuable Techs to Invest In Х х Q
Please sell these new shares on positive news and not at a deep discount. You're *******your shareholders!
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.